HYPERION DEFI, INC. Increase (Decrease) in Accrued Liabilities
HYPERION DEFI, INC. (HYPD) reported Increase (Decrease) in Accrued Liabilities of -$34.23 thousand for the 3-month period ending 2025-03-31, per its 10-Q filed 2025-05-19.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedLiabilities · last filed 2026-03-30
- HYPERION DEFI, INC. increase (decrease) in accrued liabilities for the quarter ending 2025-03-31 was -$34.23K.
- HYPERION DEFI, INC. increase (decrease) in accrued liabilities for the quarter ending 2024-12-31 was -$1.51M, a 634.93% decline year-over-year.
- HYPERION DEFI, INC. increase (decrease) in accrued liabilities for the quarter ending 2024-09-30 was $378.65K, a 4.39% increase year-over-year.
- HYPERION DEFI, INC. increase (decrease) in accrued liabilities for the quarter ending 2024-06-30 was $449.89K, a 19.67% increase year-over-year.
- HYPERION DEFI, INC. increase (decrease) in accrued liabilities for fiscal 2024 was -$1.51M.
- HYPERION DEFI, INC. increase (decrease) in accrued liabilities for fiscal 2023 was -$88.58K, a 143.51% decline from fiscal 2022.
- HYPERION DEFI, INC. increase (decrease) in accrued liabilities for fiscal 2022 was $203.57K, a 48.19% decline from fiscal 2021.
- HYPERION DEFI, INC. increase (decrease) in accrued liabilities for fiscal 2021 was $392.95K, a 68.07% increase from fiscal 2020.
| Period end | Increase (Decrease) in Accrued Liabilities 3 month | Increase (Decrease) in Accrued Liabilities 6 month | Increase (Decrease) in Accrued Liabilities 6 month as first filed | Increase (Decrease) in Accrued Liabilities 9 month | Increase (Decrease) in Accrued Liabilities 12 month |
|---|---|---|---|---|---|
| 2025-03-31 | -$34.23K 10-Q · filed 2025-05-19 | -$1.55M derived: sum of 2 quarters · filed 2026-03-30 | -$1.17M derived: sum of 3 quarters · filed 2026-03-30 | -$718.35K derived: sum of 4 quarters · filed 2026-03-30 | |
| 2024-12-31 | -$1.51M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | -$1.13M derived: sum of 2 quarters · filed 2026-03-30 | -$684.13K derived: sum of 3 quarters · filed 2026-03-30 | -$1.51M 10-K · filed 2026-03-30 | |
| 2024-09-30 | $378.65K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $828.55K derived: sum of 2 quarters · filed 2025-11-14 | -$1.78K 10-Q · filed 2025-11-14 | $281.00K derived: sum of 4 quarters · filed 2025-11-14 | |
| 2024-06-30 | $449.89K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | -$380.44K 10-Q · filed 2024-08-14 | -$97.65K derived: sum of 3 quarters · filed 2025-05-19 | $265.06K derived: sum of 4 quarters · filed 2025-05-19 | |
| 2024-03-31 | -$830.33K 10-Q · filed 2025-05-19 | -$547.55K derived: sum of 2 quarters · filed 2025-05-19 | -$184.83K derived: sum of 3 quarters · filed 2025-05-19 | $191.10K derived: sum of 4 quarters · filed 2025-05-19 | |
| 2023-12-31 | $282.78K derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-15 | $645.50K derived: sum of 2 quarters · filed 2025-04-15 | $1.02M derived: sum of 3 quarters · filed 2025-04-15 | -$88.58K 10-K · filed 2025-04-15 | |
| 2023-09-30 | $362.71K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $738.64K derived: sum of 2 quarters · filed 2024-11-12 | -$371.36K 10-Q · filed 2024-11-12 | $107.82K derived: sum of 4 quarters · filed 2024-11-12 | |
| 2023-06-30 | $375.93K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | -$734.07K 10-Q · filed 2024-08-14 | -$254.89K derived: sum of 3 quarters · filed 2024-08-14 | -$966.00 derived: sum of 4 quarters · filed 2024-08-14 | |
| 2023-03-31 | -$1.11M 10-Q · filed 2024-05-15 | -$630.82K derived: sum of 2 quarters · filed 2024-05-15 | -$376.89K derived: sum of 3 quarters · filed 2024-05-15 | -$38.20K derived: sum of 4 quarters · filed 2024-05-15 | |
| 2022-12-31 | $479.18K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-18 | $733.11K derived: sum of 2 quarters · filed 2024-03-18 | $1.07M derived: sum of 3 quarters · filed 2024-03-18 | $203.57K 10-K · filed 2024-03-18 | |
| 2022-09-30 | $253.93K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $592.62K derived: sum of 2 quarters · filed 2023-11-13 | -$275.61K 10-Q · filed 2023-11-13 | $83.77K derived: sum of 4 quarters · filed 2023-11-13 | |
| 2022-06-30 | $338.69K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-11 | -$529.53K 10-Q · filed 2023-08-11 | -$170.15K derived: sum of 3 quarters · filed 2023-08-11 | $143.42K derived: sum of 4 quarters · filed 2023-08-11 | |
| 2022-03-31 | -$868.22K 10-Q · filed 2023-05-12 | -$508.84K derived: sum of 2 quarters · filed 2023-05-12 | -$195.27K derived: sum of 3 quarters · filed 2023-05-12 | $104.66K derived: sum of 4 quarters · filed 2023-05-12 | |
| 2021-12-31 | $359.38K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $672.95K derived: sum of 2 quarters · filed 2023-03-31 | $972.89K derived: sum of 3 quarters · filed 2023-03-31 | $392.95K 10-K · filed 2023-03-31 | |
| 2021-09-30 | $313.57K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $613.50K derived: sum of 2 quarters · filed 2022-11-14 | $33.56K 10-Q · filed 2022-11-14 | $439.68K derived: sum of 4 quarters · filed 2022-11-14 | |
| 2021-06-30 | $299.93K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | -$280.01K 10-Q · filed 2022-08-11 | $126.11K derived: sum of 3 quarters · filed 2022-08-11 | $416.45K derived: sum of 4 quarters · filed 2022-08-11 | |
| 2021-03-31 | -$579.94K 10-Q · filed 2022-05-13 | -$173.82K derived: sum of 2 quarters · filed 2022-05-13 | $116.52K derived: sum of 3 quarters · filed 2022-05-13 | $222.72K derived: sum of 4 quarters · filed 2022-05-13 | |
| 2020-12-31 | $406.12K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | $696.46K derived: sum of 2 quarters · filed 2022-03-30 | $802.66K derived: sum of 3 quarters · filed 2022-03-30 | $233.80K 10-K · filed 2022-03-30 | |
| 2020-09-30 | $290.34K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | $396.55K derived: sum of 2 quarters · filed 2021-11-12 | -$172.32K 10-Q · filed 2021-11-12 | $153.06K derived: sum of 4 quarters · filed 2021-11-12 | |
| 2020-06-30 | $106.21K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | -$462.66K 10-Q · filed 2021-08-12 | -$342.97K 10-Q · filed 2020-08-14 | -$137.28K derived: sum of 3 quarters · filed 2021-08-12 | $16.52K derived: sum of 4 quarters · filed 2021-08-12 |
| 2020-03-31 | -$568.86K 10-Q · filed 2021-05-14 | -$243.49K derived: sum of 2 quarters · filed 2021-05-14 | -$89.69K derived: sum of 3 quarters · filed 2021-05-14 | -$69.05K derived: sum of 4 quarters · filed 2021-05-14 | |
| 2019-12-31 | $325.38K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-30 | $479.17K derived: sum of 2 quarters · filed 2021-03-30 | $499.81K derived: sum of 3 quarters · filed 2021-03-30 | $4.77K 10-K · filed 2021-03-30 | |
| 2019-09-30 | $153.79K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | $174.43K derived: sum of 2 quarters · filed 2020-11-12 | -$320.61K 10-Q · filed 2020-11-12 | $591.49K derived: sum of 4 quarters · filed 2020-11-12 | |
| 2019-06-30 | $20.64K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-14 | -$474.40K 10-Q · filed 2020-08-14 | $437.70K derived: sum of 3 quarters · filed 2020-08-14 | $437.70K derived: sum of 4 quarters · filed 2020-08-14 | |
| 2019-03-31 | -$495.04K 10-Q · filed 2020-05-14 | $417.06K derived: sum of 2 quarters · filed 2020-05-14 | $417.06K derived: sum of 3 quarters · filed 2020-05-14 | $417.06K derived: sum of 4 quarters · filed 2020-05-14 | |
| 2018-12-31 | $912.10K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-30 | $912.10K derived: sum of 2 quarters · filed 2020-03-30 | $912.10K derived: sum of 3 quarters · filed 2020-03-30 | $912.10K 10-K · filed 2020-03-30 | |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-13 | $0.00 derived: sum of 2 quarters · filed 2019-11-13 | $0.00 10-Q · filed 2019-11-13 | ||
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-13 | $0.00 10-Q · filed 2019-08-13 | |||
| 2018-03-31 | $0.00 10-Q · filed 2019-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |